Science Explorer Interactive view Map
Company · Solna · Sweden

Gesynta Pharma (Sweden)

gesynta.seROR OpenAlex
Research works
3
fractional, all time
Citations
56
21.9 per fractional work
Top-10% rate
2.9%
record average 16.5%
Open access
42%
world 28%

Not ranked overall: Gesynta Pharma (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which research topics does Gesynta Pharma (Sweden) publish most on?

By volume in 2022–2025: Endometriosis Research and Treatment, Inflammatory mediators and NSAID effects, Chronic Obstructive Pulmonary Disease (COPD) Research and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis.

Endometriosis Research a…0Endometriosis Research and Treatment: 0 fractional worksInflammatory mediators and NSAID effects: 0 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 0 fractional worksInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis: 0 fractional works
Reproductive MedicinePharmacologyPulmonary and Respiratory Medicine

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Endometriosis Research and Treatment Reproductive Medicine 0 works
  2. 2 Inflammatory mediators and NSAID effects Pharmacology 0 works
  3. 3 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 0 works
  4. 4 Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary and Respiratory Medicine 0 works
  5. 5 Diagnosis and Treatment of Venous Diseases Surgery 0 works
  6. 6 Sympathectomy and Hyperhidrosis Treatments Physiology 0 works
  7. 7 Systemic Sclerosis and Related Diseases Pathology and Forensic Medicine 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.5%not open58.5%

World: 28% of research is openly available.

with international co-authors20.7%domestic only79.3%

World: 19% is written across borders.

How has Gesynta Pharma (Sweden)'s research output changed?

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Solna

All research institutions in Solna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.